Mind Medicine (MindMed) Inc
MNMD15.020USD
0.0000.00%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
1.15B시가총액
손실P/E TTM
자세한 내용은 Mind Medicine (MindMed) Inc 회사
Mind Medicine (MindMed) Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. The Company is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, its lead product candidates. Its lead product candidate, MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that the Company is developing for the treatment of generalized anxiety disorder and major depressive disorder. Its second lead product candidate, MM402, also referred to as R(-)-MDMA, is its proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
Mind Medicine (MindMed) Inc 정보
종목 코드 MNMD
회사 이름Mind Medicine (MindMed) Inc
상장일May 04, 2015
CEOBarrow (Robert B)
직원 수74
유형Ordinary Share
회계 연도 종료May 04
주소One World Trade Center
도시NEW YORK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호10007
전화12122206633
웹사이트https://ir.mindmed.co/
종목 코드 MNMD
상장일May 04, 2015
CEOBarrow (Robert B)
Mind Medicine (MindMed) Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Robert (Rob) Barrow
Mr. Robert (Rob) Barrow
Chief Executive Officer, Director
Chief Executive Officer, Director
518.46K
+320000.00%
Mr. Mark R. Sullivan
Mr. Mark R. Sullivan
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
20.08K
-11276.00%
Dr. Suzanne Louise (Sue) Bruhn, Ph.D.
Dr. Suzanne Louise (Sue) Bruhn, Ph.D.
Independent Director
Independent Director
17.64K
+5402.00%
Dr. Roger Crystal, M.D.
Dr. Roger Crystal, M.D.
Independent Director
Independent Director
17.64K
+5402.00%
Mr. David W. (Dave) Gryska
Mr. David W. (Dave) Gryska
Independent Director
Independent Director
10.62K
-9234.00%
Dr. Daniel R. Karlin, M.D.
Dr. Daniel R. Karlin, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Andreas R. Krebs
Mr. Andreas R. Krebs
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Carol A. Vallone
Ms. Carol A. Vallone
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Matthew T. Wiley
Mr. Matthew T. Wiley
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Chris Brinzey
Mr. Chris Brinzey
IR Contact Officer
IR Contact Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Robert (Rob) Barrow
Mr. Robert (Rob) Barrow
Chief Executive Officer, Director
Chief Executive Officer, Director
518.46K
+320000.00%
Mr. Mark R. Sullivan
Mr. Mark R. Sullivan
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
20.08K
-11276.00%
Dr. Suzanne Louise (Sue) Bruhn, Ph.D.
Dr. Suzanne Louise (Sue) Bruhn, Ph.D.
Independent Director
Independent Director
17.64K
+5402.00%
Dr. Roger Crystal, M.D.
Dr. Roger Crystal, M.D.
Independent Director
Independent Director
17.64K
+5402.00%
Mr. David W. (Dave) Gryska
Mr. David W. (Dave) Gryska
Independent Director
Independent Director
10.62K
-9234.00%
Dr. Daniel R. Karlin, M.D.
Dr. Daniel R. Karlin, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Feb 7
마지막 업데이트: Sat, Feb 7
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
5.34%
Commodore Capital LP
3.27%
Driehaus Capital Management, LLC
3.16%
Blackstone Alternative Asset Management, L.P.
2.82%
The Vanguard Group, Inc.
2.61%
기타
82.80%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
5.34%
Commodore Capital LP
3.27%
Driehaus Capital Management, LLC
3.16%
Blackstone Alternative Asset Management, L.P.
2.82%
The Vanguard Group, Inc.
2.61%
기타
82.80%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
16.81%
Investment Advisor
13.43%
Hedge Fund
11.26%
Research Firm
1.58%
Individual Investor
1.28%
Private Equity
0.37%
Bank and Trust
0.33%
Pension Fund
0.13%
Venture Capital
0.10%
기타
54.71%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
415
43.34M
43.99%
-6.62M
2025Q3
385
42.65M
43.29%
-5.82M
2025Q2
380
42.59M
55.97%
-6.05M
2025Q1
383
42.99M
56.91%
-5.37M
2024Q4
358
42.80M
58.58%
-14.39M
2024Q3
346
50.91M
62.84%
+1.65M
2024Q2
371
44.11M
63.15%
+4.97M
2024Q1
368
37.27M
54.54%
+28.87M
2023Q4
362
7.25M
18.10%
-366.43K
2023Q3
378
6.32M
16.16%
-494.13K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
5.26M
5.34%
+38.15K
+0.73%
Sep 30, 2025
Commodore Capital LP
3.23M
3.27%
-1.77M
-35.50%
Sep 30, 2025
Driehaus Capital Management, LLC
3.11M
3.16%
+17.25K
+0.56%
Sep 30, 2025
Blackstone Alternative Asset Management, L.P.
2.78M
2.82%
-810.92K
-22.60%
Sep 30, 2025
The Vanguard Group, Inc.
2.00M
2.03%
+198.88K
+11.04%
Sep 30, 2025
Marshall Wace LLP
2.38M
2.42%
-1.04M
-30.38%
Sep 30, 2025
Octagon Capital Advisors LP
2.13M
2.16%
--
--
Sep 30, 2025
State Street Investment Management (US)
1.92M
1.95%
+119.00K
+6.59%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.82M
1.85%
+91.25K
+5.26%
Sep 30, 2025
Deep Track Capital LP
1.50M
1.52%
-1.00M
-40.00%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
AdvisorShares Psychedelics ETF
9.95%
State Street SPDR S&P Pharmaceuticals ETF
2.17%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.54%
Virtus LifeSci Biotech Clinical Trials ETF
1.32%
iShares U.S. Pharmaceuticals ETF
0.4%
iShares Micro-Cap ETF
0.21%
ProShares Ultra Nasdaq Biotechnology
0.11%
Invesco Nasdaq Biotechnology ETF
0.11%
Nuveen ESG Small-Cap ETF
0.08%
iShares ESG Aware MSCI USA Small-Cap ETF
0.07%
더 보기
AdvisorShares Psychedelics ETF
비율9.95%
State Street SPDR S&P Pharmaceuticals ETF
비율2.17%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
비율1.54%
Virtus LifeSci Biotech Clinical Trials ETF
비율1.32%
iShares U.S. Pharmaceuticals ETF
비율0.4%
iShares Micro-Cap ETF
비율0.21%
ProShares Ultra Nasdaq Biotechnology
비율0.11%
Invesco Nasdaq Biotechnology ETF
비율0.11%
Nuveen ESG Small-Cap ETF
비율0.08%
iShares ESG Aware MSCI USA Small-Cap ETF
비율0.07%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Aug 23, 2022
Merger
15→1
Aug 23, 2022
Merger
15→1
Aug 23, 2022
Merger
15→1
Aug 23, 2022
Merger
15→1
날짜
배당락일
유형
비율
Aug 23, 2022
Merger
15→1
Aug 23, 2022
Merger
15→1
Aug 23, 2022
Merger
15→1
Aug 23, 2022
Merger
15→1
